Mometasone Furoate Market, By Form of Dose (Nasal Spray, Cream, Ointment, Inhalers, and Others), By Sales Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), By Administration Route (Nasal Administration, Topical, and Oral), By Indication (Inflammatory Skin Disorders, Asthma, Allergic rhinitis, and Others), By Region Analysis - Global Analysis And Industry Forecast Report Till 2030.

The Mometasone Furoate Market is projected to grow from $1.18 billion to $2.21 billion, at a CAGR of 7.2% during the forecast period 2021-2030.

Mometasone, also called mometasone furoate, is a corticosteroid used to treat asthma, hay fever, and several skin problems. Instead of managing asthma attacks, mometasone furoate is used primarily for prophylaxis. It reduces inflammation, itching, and redness by inhibiting infection-fighting white blood cells from reaching the infected area. It also inhibits the chemical messengers that cause allergic reactions in the body. Symptoms of various skin allergies as well as other allergic diseases such as hay fever and allergic rhinitis are effectively treated by mometasone furoate.

Mometasone inhibits mast cells, lymphocytes, basophils and eosinophils in case of asthma to prevent asthma attacks. According to the American Academy of Dermatology, 1 in 10 people will suffer from dermatitis during their lifetime, while around 7.5 million people in the United States have psoriasis. The advancements in the treatment and awareness about mometasone are the major driving factors of the Mometasone Furoate Market.

Mometasone furoate is a potent corticosteroid commonly used in various dermatological treatments. It is available in different forms, such as mometasone furoate cream, mometasone furoate ointment, and mometasone furoate spray. These formulations are utilized to address a range of skin conditions, including eczema, psoriasis, and allergic reactions. Mometasone furoate cream is particularly favored for its ease of application and absorption, providing relief from itching, redness, and inflammation. With its anti-inflammatory properties, mometasone furoate effectively reduces skin irritation and promotes healing, making it a trusted choice among healthcare professionals and patients alike.

Market Dynamics:

Drivers:

An increase in research and development activities on mometasone furoate formulations and development is expected to propel the growth of the global mometasone furoate market over the forecast period. For example, according to a research article published in the Journal of Dermatological Treatment, in 2022, a study was conducted in India, the purpose of which was to develop aspasomal mometasone furoate, which is biologically active and delivers drugs at a controlled rate. It was to develop a minimal dose required to treat psoriasis. Aspasomal gel with mometasone furoate was developed and found that aspasomal gel with mometasone furoate delivered the drug for a longer period of time and required lower doses, thereby expanding the scope of psoriasis treatment. These are the major factors boosting the growth of this market.

Restraints:

Mometasone in the form of a nasal spray can cause side effects such as headache, viral upper respiratory infection, sore throat, nosebleeds, cough, and muscle and joint pain. Adverse effects associated with mometasone furoate are expected to hamper the growth of global mometasone furoate over the forecast period.

Opportunities:

Market participants are participating in product approvals, which are expected to fuel the global mometasone furoate market growth over the forecast period. For example, in 2022, Perrigo Company plc, a private label generic drug manufacturer based in Ireland, announced that the US Food and Drug Administration has approved Nasonex 24HR Allergy (Mometasone Furoate) Nasal Spray. It treats hay fever or other upper respiratory allergy symptoms such as stuffy nose, runny nose, sneezing, and itchy nose. These factors are contributing to bringing many opportunities in this market.

Key Players:

• Teva Pharmaceuticals

• Glenmark Pharmaceuticals

• AdvaCare Pharma

• Medlab Pharmaceuticals Private Limited

• Dermocare Laboratories

• Iva Healthcare Private Limited

• Unilab Chemicals & Pharmaceuticals Pvt Ltd

• Organon group of companies

• Cosette Pharmaceuticals

• Taro Pharmaceutical Industries Ltd.

• Hikma Pharmaceuticals

• Cipla

Market Segmentation:

Mometasone Furoate Market, By Form of Dose

• Nasal Spray

• Cream

• Ointment

• Inhalers

• Others 

Mometasone Furoate Market, By Indication

• Inflammatory Skin Disorders

• Asthma

• Allergic rhinitis

• Others

Mometasone Furoate Market, By Administration Route

• Nasal Administration

• Topical

• Oral

Mometasone Furoate Market, By Sales Channel

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

Mometasone Furoate Market, By Region Type

• North America 

• Europe 

• Asia-Pacific 

• LAMEA 

Regional Analysis:

North America will continue to dominate the mometasone furoate market over the next decade with high approval rates and commercialization of biopharmaceuticals. It is regarded as the largest region in this market. Increasing awareness and availability of advanced technologies fuels the demand for the mometasone market in North America.

Asia Pacific is lucrative with the high growth rate of the mometasone market during the forecast period. It is anticipated to be the fastest-growing region in this market. Owing to the growing population of patients with inflammatory skin diseases and the increasing number of domestic manufacturers in this region, Asia Pacific is favorable for the mometasone market growth.

Scope of the report:

User

Tab Content